1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Antacid Market – By Dosage Form

1.3.2        Antacid Market – By Drug Class

1.3.3        Antacid Market – By Distribution Channel

1.3.4        South and Central America Antacid Market – By Country

2.           South and Central America Antacid Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South and Central America Antacid Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Antacid Market- South and Central America PEST Analysis

4.3         Expert Opinion

5.           South and Central America Antacid Market - Key Market Dynamics

5.1         Market Drivers

5.1.1        Rise in Prevalence of Gastroesophageal Reflux Disease (GERD)

5.1.2        Increase in Prevalence of Obesity

5.2         Market Restraints

5.2.1        Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies

5.3         Market Opportunities

5.3.1        Increasing Research Activities and Research Funds on GI Disorders

5.4         Future Trends

5.4.1        Rising Development of the Pharmaceutical Industry

5.5         Impact Analysis

6.           Antacid Market – South and Central America Analysis

6.1         South and Central America Antacid Market Revenue Forecasts and Analysis

7.           South and Central America Antacid Market Analysis and Forecasts To 2027 – By Dosage Form

7.1         Overview

7.2         Antacid Market Revenue Share, by Dosage Form (2019 and 2027)

7.3         Tablet

7.3.1        Overview

7.3.2        Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Liquid

7.4.1        Overview

7.4.2        Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Others

7.5.1        Overview

7.5.2        Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.           South and Central America Antacid Market Analysis and Forecasts to 2027– By Drug Class

8.1         Overview

8.2         Antacid Market Revenue Share, by Drug Class (2019 and 2027)

8.3         Proton Pump Inhibitors

8.3.1        Overview

8.3.2        Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.4         H Antagonist

8.4.1        Overview

8.4.2        H Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Acid Neutralizers

8.5.1        Overview

8.5.2        Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5.3        Magaldrate

8.5.3.1          Overview

8.5.3.2          Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5.4        Sucralfate

8.5.4.1          Overview

8.5.4.2          Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5.5        Others

8.5.5.1          Overview

8.5.5.2          Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

9.           South and Central America Antacid Market Analysis and Forecasts to 2027– By Distribution Channel

9.1         Overview

9.2         Antacid Market Share, by Distribution Channel, 2019 and 2027, (%)

9.3         Hospital Pharmacy

9.3.1        Overview

9.3.2        Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Retail Pharmacy

9.4.1        Overview

9.4.2        Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

9.5         Online Pharmacy

9.5.1        Overview

9.5.2        Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

10.        Antacid Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1      South and Central America: Antacid Market

10.1.1     Overview

10.1.3     South and Central America: Antacid Market, by Country, 2019 & 2027 (%)

10.1.4     Brazil: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.1       Brazil: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.2       Brazil: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.1.4.3       Brazil: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.1.4.3.1       Brazil: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.4.4       Brazil: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.5     Argentina: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.1       Argentina: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.2       Argentina: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.1.5.3       Argentina: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.1.5.3.1       Argentina: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.5.4       Argentina: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.6     Rest of South and Central America: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.1       Rest of South and Central America: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.2       Rest of South and Central America: Antacid Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)

10.1.6.3       Rest of South and Central America: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.1.6.3.1       Rest of South and Central America: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.6.4       Rest of South and Central America: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.        Impact Of COVID-19 Pandemic on South and Central America Antacid Market

11.1      South and Central America: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        COMPANY PROFILES

13.1      Bayer AG

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Takeda Pharmaceutical Company Limited

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Sun Pharmaceutical Industries Ltd

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Sanofi

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Boehringer Ingelheim International GmbH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Dr. Reddy's Laboratories

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Pfizer Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     roducts and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Reckitt Benckiser Group Plc

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Procter & Gamble

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Brazil: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 2.             Brazil: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 3.             Brazil: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             Brazil: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 5.             Argentina: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 6.             Argentina: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 7.             Argentina: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             Argentina: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9.             Rest of South and Central America: Antacid Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)

Table 10.          Rest of South and Central America: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 11.          Rest of South and Central America: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Rest of South and Central America: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          Organic Developments Done By Companies

Table 14.          Inorganic Developments Done By Companies

Table 15.          Glossary of Terms, Antacid Market

LIST OF FIGURES

Figure 1.           Antacid Market Segmentation

Figure 2.           South and Central America Antacid Market Overview

Figure 3.           Proton Pump Inhibitors Segment Held Largest Share of Drug Class in Antacid Market

Figure 4.           Tablet Segment Held Largest Share of Dosage Form in Antacid Market

Figure 5.           Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Antacid Market - South and Central America PEST Analysis

Figure 7.           Antacid Market Impact Analysis of Driver and Restraints

Figure 8.           South and Central America Antacid Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           Antacid Market Revenue Share, by Dosage Form (2019 and 2027)

Figure 10.        Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Antacid Market Revenue Share, by Drug Class (2019 and 2027)

Figure 14.        Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        H Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Antacid Market Share, by Distribution Channel, 2019 and 2027 (%)

Figure 21.        Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        South and Central America: Antacid Market, by Key Country – Revenue (2019) (USD Million)

Figure 25.        South and Central America: Antacid Market, by Country, 2019 & 2027 (%)

Figure 26.        Brazil: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        Argentina: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Rest of South and Central America: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Impact of COVID-19 Pandemic in South and Central America Country Markets

Figure 30.        Growth Strategies Done by the Companies in the Market, (%)